Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

During the Trading Day
2.58 -0.15 / -5.49%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
2.63 +0.05 / +1.94%
Volume: 250.00

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues5.5M20.1M29.9M27.1M
Depreciation And Amortization75.0K100.0K227.0K223.0K
Operating ExpensesGross Income5.4M------
General Expenses27.7M47.6M65.0M56.6M
Research And Development21.6M39.9M55.3M46.2M
Total Operating Expenses27.8M47.7M65.2M56.8M
Non-Operating ExpensesOperating Income-22.3M-27.6M-35.3M-29.7M
Extraordinary Credit7.4M6.3M3.2M4.0M
Extraordinary Charge0.000.000.00-531.0K
Other Expenses6.0K-62.0K120.0K-19.0K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.7M-21.1M-31.8M-26.2M
Net Income-14.7M-21.1M-31.8M-26.2M
Shares To Calculate EPSShares To Calculate EPS9.7M13.5M14.7M18.1M
Shares To Calculate EPS Diluted9.7M13.5M14.7M18.1M
Earnings Per ShareEPS-$1.51-$1.56-$2.17-$1.45
EPS Diluted-$1.51-$1.56-$2.17-$1.45